UNDP and Global Fund Deliver 23 Tonnes of Life-Saving Medication to Eastern DRC After Months of Shortages

UNDP and Global Fund Deliver 23 Tonnes of Life-Saving Medication to Eastern DRC After Months of Shortages

Goma, 18 June 2025 — In a major breakthrough for communities in crisis in the Democratic Republic of Congo (DRC), the United Nations Development Programme (UNDP) and the The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) have delivered 23 tonnes of essential HIV and Tuberculosis medication to North Kivu and South Kivu provinces. This shipment, which follows months of severe shortages due to conflict and looting, … Continue reading UNDP and Global Fund Deliver 23 Tonnes of Life-Saving Medication to Eastern DRC After Months of Shortages

sanofi

Sanofi to Acquire Blueprint Medicines for approximately to $9.5B

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio Press Release – Paris and Cambridge, MA. June 2, 2025. Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and … Continue reading Sanofi to Acquire Blueprint Medicines for approximately to $9.5B

G2 Speech Launches Aida

G2 Speech Launches Aida

The impactful, conversational and people-centric AI speech solution that delivers efficiencies for healthcare professionals with ease.  Press Release – 21st May 2025– Speech recognition and AI provider, G2 Speech, has announced the launch of Aida – its latest AI innovation. Aida (G2 Speech’s AI Digital Assistant) has been built specifically for medical specialists to enrich clinical reporting by further automating the medical documentation process with unparallelled … Continue reading G2 Speech Launches Aida

Kamel Ghribi Attends Pope Leo XIV’s Inauguration

Kamel Ghribi Attends Pope Leo XIV’s Inauguration, Reflects on New Era of Humble Power and Global Unity

Pope Leo XIV’s inauguration mass took place on Sunday, May 18, 2025, marking a profound moment in the history of the Catholic Church. The event, which resonated far beyond the walls of the Vatican, was witnessed by many global dignitaries, including veteran businessman and humanitarian Kamel Ghribi. Reflecting on the ceremony, Ghribi described it as “a sacred moment etched into the heart of history… one … Continue reading Kamel Ghribi Attends Pope Leo XIV’s Inauguration, Reflects on New Era of Humble Power and Global Unity

Abu Dhabi $200 Billion Strategic Engine: Powering the Future of Global Investment and Innovation

Abu Dhabi $200 Billion Strategic Engine: Powering the Future of Global Investment and Innovation

Once viewed primarily as an oil-rich capital, Abu Dhabi has rapidly transformed into one of the world’s most forward-thinking investment hubs. At the core of this evolution lies a $200 billion strategic engine – an interconnected network of sovereign wealth funds, industrial diversification, global partnerships, and technology-driven innovation. This ecosystem is not only redefining the Emirate’s economic future but is also influencing how the world … Continue reading Abu Dhabi $200 Billion Strategic Engine: Powering the Future of Global Investment and Innovation

Voyager Acquisition Corp. Announce Business Combination Agreement

‍Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company focused on the development of a comprehensive pipeline of next-generation cancer therapies. · VERAXA’s Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate (“ADC”) and Bispecific T-cell Engager (“TCE”) Candidates, with Strong and Differentiated Clinical Profiles · Company Pursuing Multiple Strategic Partnerships and Licensing … Continue reading ‍Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

Olympus Appoints New CEO -  Bob White

Olympus Appoints New CEO –  Bob White

Names Bob White Representative Executive Officer, President, Chief Executive Officer and a new Director candidate News Release – TOKYO, April 25, 2025 – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announces appointment of a Chief Executive Officer (CEO) aimed at accelerating its ongoing transformation efforts in the medtech space. The Board of Directors has … Continue reading Olympus Appoints New CEO –  Bob White

Aviceda Therapeutics Appoints Dr. Jeffrey Nau as Chief Executive Officer

Aviceda Therapeutics Appoints Dr. Jeffrey Nau as Chief Executive Officer

Press Release – CAMBRIDGE, Mass. – Aviceda Therapeutics (“Aviceda”), a private, clinical-stage biotech company focused on developing next-generation immunomodulators incorporating its proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform with an aim to alleviate chronic, non-resolving inflammation, today announced the appointment of Jeffrey Nau, Ph.D., M.M.S., as Chief Executive Officer (CEO), effective immediately. Dr. Nau will also join the Aviceda Board of Directors. Dr. Nau … Continue reading Aviceda Therapeutics Appoints Dr. Jeffrey Nau as Chief Executive Officer

New Guideline Aims to Transform Obesity Care for Children and Adolescents

New Guideline Aims to Transform Obesity Care for Children and Adolescents

First Canadian update in nearly 20 years prioritizes improvements in health and quality of life over weight loss outcomes.  Press Release – April 14, 2025 – EDMONTON, AB – Healthcare providers and families have a new roadmap to support collaborative, fully-informed, evidence-based care for children and adolescents living with obesity, thanks to a new clinical practice guideline published today in the Canadian Medical Association Journal.  The … Continue reading New Guideline Aims to Transform Obesity Care for Children and Adolescents